Results for bioequivalence translation from Dutch to French

investigation of bioavailability and bioequivalence
c linical investigation of medicinal products in the treatment of schizophrenia

the conduct of bioequivalence studies for
safety studies for veterinary drug residues in human food:

note for guidance on the investigation of bioavailability and bioequivalence
note for guidance on the investigation of bioavailability and bioequivalence

note for guidance on the investigation of bioavailability and bioequivalence note for guidance on co-ordinating
note for guidance on repeated dose toxicity adoptée en juillet 2000

note for guidance on non-clinical testing of herbal drug preparations with long-term marketing experience - guidance to facilitate mutual recognition and use of bibliographic data concept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/bioequivalence of herbal drugs/preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal products containing á- and β -asarone position paper on the use of sassafras albidum as active substance or ingredient in herbal medicinal products concept paper on the levels of scientific evidence required for the authorisation of well-established use and traditional herbal medicinal products core-data on urticae radix core-data on lini semen core-data on rosmarini folium cum flore core-data on primulae radix
note for guidance on non-clinical testing of herbal drug preparations with long-term marketing experience - guidance facilitate mutual recognition and use of bibliographic data concept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/ bioequivalence of herbal drugs/ preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal products containing á- and β -asarone position paper on the use of sassafras albidum as active substance or ingredient in herbal medicinal products